- J-STAGE home
- /
- Japanese Journal of Extra-Corp ...
- /
- Volume 34 (2007) Issue 4
- /
- Article overview
-
Hideki Yotsuida
Department of Operation, National Cardiovascular Center
-
Yasunori Yamasaki
Department of Operation, National Cardiovascular Center
-
Takayuki Nishigaki
Department of Operation, National Cardiovascular Center
-
Yuzo Takahashi
Department of Operation, National Cardiovascular Center
-
Kotaro Yoshida
Department of Operation, National Cardiovascular Center
-
Risako Miki
Department of Operation, National Cardiovascular Center
-
Koji Ogawa
Department of Operation, National Cardiovascular Center
-
Mai Kaneko
Department of Operation, National Cardiovascular Center
-
Ryoji Sada
Department of Operation, National Cardiovascular Center
-
Hiroshi Nishioka
Department of Operation, National Cardiovascular Center
-
Yuka Kinoshita
Department of Operation, National Cardiovascular Center
-
Junichi Togesaki
Department of Operation, National Cardiovascular Center
-
Masami Mitani
Department of Operation, National Cardiovascular Center
-
Yasufumi Matsumoto
Department of Operation, National Cardiovascular Center
-
Yasuhiro Yamanaka
Department of Operation, National Cardiovascular Center
-
Teruyuki Hayashi
Department of Operation, National Cardiovascular Center
2007 Volume 34 Issue 4 Pages 301-304
- Published: December 01, 2007 Received: - Available on J-STAGE: June 28, 2010 Accepted: - Advance online publication: - Revised: -
-
Correction information
Date of correction: June 28, 2010 Reason for correction: - Correction: ABSTRACT Details: [in Japanese]
Date of correction: June 28, 2010 Reason for correction: - Correction: KEYWORD Details: Wrong : Key words: Heparin induced thrombocytopenia, HIT, CPB, Argatroban
Right : Heparin induced thrombocytopenia, HIT, CPB, Argatroban
Date of correction: June 28, 2010 Reason for correction: - Correction: CITATION Details: Wrong : E
E
E
E
E
E
E
E
Right : 1)Warkentin TE: heparin-induced thrombocytopenia, diagnosis and management. Circulation, 110; e454-e458, 2004.
3)Okamoto S, Hijikata A, Kimoto?, et al.: Potent inhibition of thrombin by the newly synthesized arginine derivative No 850. Biochemical and Biophysical Research Communication, 101(2); 440-446, 1981.
4)Lewis BE, Wallis DE, Kelton JG: ARG 911 study investigators. Argatroban anticoagulant therapy in patients whit heparin induced thrombocytopenia. Circulation, 103; 1838-1843 2001.
5)Grocott HP, Root J, Berkowitz SD, et al,: Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium. J cardiothorac Vasc anesth, 11; 875-877, 1997.
6)Bruce E, Marcie J: Argatroban Therapy in Heparin-induced Thrombocytopenia: Heparin-Induced Thrombocytoperlia Second Edition. P. 381.
7)Okamoto S, Hijikata-Okunomiya A: synthetic selective inhibitors of thrombin. Methods Enzymol 222: 328-340, 1993
(compatible with EndNote, Reference Manager, ProCite, RefWorks)
(compatible with BibDesk, LaTeX)
